Literature DB >> 6199278

Elastase inhibition by the inter-alpha-trypsin inhibitor and derived inhibitors of man and cattle.

G J Albrecht, K Hochstrasser, J P Salier.   

Abstract

The inhibitory properties of HI-14 and BI-14, the active 14-kDa parts released from the corresponding human and bovine inter-alpha-trypsin inhibitors, are compared. The structurally homologous inhibitors composed of two tandem Kunitz-type domains differ in their inhibitory specificity, although the reactive site residue in position P1 is occupied by identical (arginine in the C-terminal domain II) or similar (methionine and leucine in the N-terminal domain I of HI-14 and BI-14, respectively) amino-acid residues. The N-terminal domain I of HI-14 is completely inactive against chymotrypsin and pancreatic elastase, whereas BI-14 is a strong inhibitor of these enzymes. Elastase from polymorphonuclear granulocytes interacts with both inhibitors but with different affinities. Compared with the bovine inhibitor, the human inhibitor shows a much lower affinity from this enzyme. Human ITI and its physiological 30-kDa derivative (HI-30) show the same inhibitory properties as HI-14. The differences between human and bovine inhibitors might be explained by a preceding oxidation of Met in vivo of the reactive site residue in position P1 and/or by the influence of the environmental parts connected with this antielastase reactive site region in human ITI or in the active domains thereof.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6199278     DOI: 10.1515/bchm2.1983.364.2.1703

Source DB:  PubMed          Journal:  Hoppe Seylers Z Physiol Chem        ISSN: 0018-4888


  6 in total

1.  The mRNA for a proteinase inhibitor related to the HI-30 domain of inter-alpha-trypsin inhibitor also encodes alpha-1-microglobulin (protein HC).

Authors:  J F Kaumeyer; J O Polazzi; M P Kotick
Journal:  Nucleic Acids Res       Date:  1986-10-24       Impact factor: 16.971

2.  Modification of the tandem reactive centres of human inter-alpha-trypsin inhibitor with butanedione and cis-dichlorodiammineplatinum(II).

Authors:  M W Swaim; S V Pizzo
Journal:  Biochem J       Date:  1988-08-15       Impact factor: 3.857

3.  Urinary trypsin inhibitor (UTI) and fragments derived from UTI by limited proteolysis efficiently inhibit tumor cell invasion.

Authors:  H Kobayashi; H Shinohara; H Ohi; M Sugimura; T Terao; M Fujie
Journal:  Clin Exp Metastasis       Date:  1994-03       Impact factor: 5.150

4.  Interaction of human mast cell tryptase and chymase with low-molecular-mass serine proteinase inhibitors from the human respiratory tract.

Authors:  K Hochstrasser; W Gebhard; G Albrecht; G Rasp; E Kastenbauer
Journal:  Eur Arch Otorhinolaryngol       Date:  1993       Impact factor: 2.503

5.  Simukunin from the salivary glands of the black fly Simulium vittatum inhibits enzymes that regulate clotting and inflammatory responses.

Authors:  Hitoshi Tsujimoto; Michail Kotsyfakis; Ivo M B Francischetti; Jai Hoon Eum; Michael R Strand; Donald E Champagne
Journal:  PLoS One       Date:  2012-02-23       Impact factor: 3.240

6.  Anti-metastatic therapy by urinary trypsin inhibitor in combination with an anti-cancer agent.

Authors:  H Kobayashi; H Shinohara; J Gotoh; M Fujie; S Fujishiro; T Terao
Journal:  Br J Cancer       Date:  1995-11       Impact factor: 7.640

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.